Do analysts rate TKNO or MGTX?

MeiraGTx has a consensus price target of $26.00, indicating a potential upside of 111.09%. Given MeiraGTx's stronger consensus rating and higher probable upside, analysts plainly believe MeiraGTx is more favorable than Alpha Teknova. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Alpha Teknova 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 MeiraGTx 1 Sell rating(s) 1 Hold rating(s) 5 Buy rating(s) 1 Strong Buy rating(s) 2.75

Is TKNO or MGTX more profitable?

Alpha Teknova has a net margin of -41.07% compared to MeiraGTx's net margin of -151.12%. MeiraGTx's return on equity of 0.00% beat Alpha Teknova's return on equity. Company Net Margins Return on Equity Return on Assets Alpha Teknova -41.07% -24.32% -16.34% MeiraGTx -151.12% N/A -54.96%

Does the media prefer TKNO or MGTX?

In the previous week, MeiraGTx had 1 more articles in the media than Alpha Teknova. MarketBeat recorded 2 mentions for MeiraGTx and 1 mentions for Alpha Teknova. MeiraGTx's average media sentiment score of 0.68 beat Alpha Teknova's score of 0.00 indicating that MeiraGTx is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Alpha Teknova 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral MeiraGTx 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer TKNO or LBRX?

LB Pharmaceuticals has a consensus target price of $45.13, indicating a potential upside of 0.16%. Given LB Pharmaceuticals' stronger consensus rating and higher possible upside, analysts plainly believe LB Pharmaceuticals is more favorable than Alpha Teknova. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Alpha Teknova 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 LB Pharmaceuticals 1 Sell rating(s) 1 Hold rating(s) 6 Buy rating(s) 2 Strong Buy rating(s) 2.90

Does the media prefer TKNO or LBRX?

In the previous week, LB Pharmaceuticals had 6 more articles in the media than Alpha Teknova. MarketBeat recorded 7 mentions for LB Pharmaceuticals and 1 mentions for Alpha Teknova. LB Pharmaceuticals' average media sentiment score of 0.59 beat Alpha Teknova's score of 0.00 indicating that LB Pharmaceuticals is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Alpha Teknova 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral LB Pharmaceuticals 1 Very Positive mention(s) 3 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts rate TKNO or FBRX?

Forte Biosciences has a consensus price target of $72.50, indicating a potential downside of 5.30%. Given Forte Biosciences' stronger consensus rating and higher probable upside, analysts clearly believe Forte Biosciences is more favorable than Alpha Teknova. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Alpha Teknova 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 Forte Biosciences 1 Sell rating(s) 4 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.14

Does the media refer more to TKNO or FBRX?

In the previous week, Forte Biosciences had 8 more articles in the media than Alpha Teknova. MarketBeat recorded 9 mentions for Forte Biosciences and 1 mentions for Alpha Teknova. Forte Biosciences' average media sentiment score of 0.35 beat Alpha Teknova's score of 0.00 indicating that Forte Biosciences is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Alpha Teknova 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Forte Biosciences 2 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts prefer TKNO or CRON?

Cronos Group has a consensus price target of $2.30, suggesting a potential downside of 18.29%. Given Cronos Group's stronger consensus rating and higher possible upside, analysts plainly believe Cronos Group is more favorable than Alpha Teknova. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Alpha Teknova 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 Cronos Group 1 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.20

Which has better valuation & earnings, TKNO or CRON?

Cronos Group has higher revenue and earnings than Alpha Teknova. Alpha Teknova is trading at a lower price-to-earnings ratio than Cronos Group, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Alpha Teknova $40.52M 7.27 -$17.26M -$0.32 N/A Cronos Group $146.59M 7.16 -$9.45M $0.01 281.50

Does the media prefer TKNO or CRON?

In the previous week, Cronos Group had 2 more articles in the media than Alpha Teknova. MarketBeat recorded 3 mentions for Cronos Group and 1 mentions for Alpha Teknova. Cronos Group's average media sentiment score of 0.25 beat Alpha Teknova's score of 0.00 indicating that Cronos Group is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Alpha Teknova 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Cronos Group 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts rate ALVO or TKNO?

Alvotech presently has a consensus target price of $7.60, indicating a potential upside of 97.97%. Given Alvotech's stronger consensus rating and higher possible upside, equities research analysts clearly believe Alvotech is more favorable than Alpha Teknova. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Alvotech 2 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.00 Alpha Teknova 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50

Which has preferable valuation and earnings, ALVO or TKNO?

Alvotech has higher revenue and earnings than Alpha Teknova. Alpha Teknova is trading at a lower price-to-earnings ratio than Alvotech, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Alvotech $588.90M 1.97 $27.92M -$0.25 N/A Alpha Teknova $40.52M 7.27 -$17.26M -$0.32 N/A

Is ALVO or TKNO more profitable?

Alvotech has a net margin of -14.36% compared to Alpha Teknova's net margin of -41.07%. Alvotech's return on equity of -11.92% beat Alpha Teknova's return on equity. Company Net Margins Return on Equity Return on Assets Alvotech -14.36% -11.92% -7.59% Alpha Teknova -41.07% -24.32% -16.34%

Does the media favor ALVO or TKNO?

In the previous week, Alvotech had 6 more articles in the media than Alpha Teknova. MarketBeat recorded 7 mentions for Alvotech and 1 mentions for Alpha Teknova. Alvotech's average media sentiment score of 1.25 beat Alpha Teknova's score of 0.00 indicating that Alvotech is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Alvotech 6 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Alpha Teknova 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Alpha Teknova (TKNO) Competitors

$5.50 +0.20 (+3.74%)

Closing price 03:59 PM Eastern

Extended Trading

$5.52 +0.02 (+0.31%)

As of 04:10 PM Eastern

Compare

TKNO vs. MGTX, LBRX, FBRX, CRON, and ALVO

Should you buy Alpha Teknova stock or one of its competitors? MarketBeat compares Alpha Teknova with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Alpha Teknova include MeiraGTx (MGTX), LB Pharmaceuticals (LBRX), Forte Biosciences (FBRX), Cronos Group (CRON), and Alvotech (ALVO).

How does Alpha Teknova compare to MeiraGTx?

Alpha Teknova (NASDAQ:TKNO) and MeiraGTx (NASDAQ:MGTX) are both small-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their valuation, institutional ownership, earnings, media sentiment, risk, profitability, analyst recommendations and dividends.

In the previous week, MeiraGTx had 1 more articles in the media than Alpha Teknova. MarketBeat recorded 2 mentions for MeiraGTx and 1 mentions for Alpha Teknova. MeiraGTx's average media sentiment score of 0.68 beat Alpha Teknova's score of 0.00 indicating that MeiraGTx is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Alpha Teknova	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
MeiraGTx	1 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Alpha Teknova has a beta of 0.64, meaning that its share price is 36% less volatile than the broader market. Comparatively, MeiraGTx has a beta of 1.23, meaning that its share price is 23% more volatile than the broader market.

Alpha Teknova has a net margin of -41.07% compared to MeiraGTx's net margin of -151.12%. MeiraGTx's return on equity of 0.00% beat Alpha Teknova's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Alpha Teknova	-41.07%	-24.32%	-16.34%
MeiraGTx	-151.12%	N/A	-54.96%

MeiraGTx has a consensus price target of $26.00, indicating a potential upside of 111.09%. Given MeiraGTx's stronger consensus rating and higher probable upside, analysts plainly believe MeiraGTx is more favorable than Alpha Teknova.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Alpha Teknova	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
MeiraGTx	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	2.75

13.8% of Alpha Teknova shares are owned by institutional investors. Comparatively, 67.5% of MeiraGTx shares are owned by institutional investors. 13.2% of Alpha Teknova shares are owned by insiders. Comparatively, 7.4% of MeiraGTx shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Alpha Teknova has higher earnings, but lower revenue than MeiraGTx. Alpha Teknova is trading at a lower price-to-earnings ratio than MeiraGTx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Alpha Teknova	$40.52M	7.27	-$17.26M	-$0.32	N/A
MeiraGTx	$81.39M	14.01	-$114.20M	-$1.48	N/A

Summary

MeiraGTx beats Alpha Teknova on 12 of the 17 factors compared between the two stocks.

How does Alpha Teknova compare to LB Pharmaceuticals?

Alpha Teknova (NASDAQ:TKNO) and LB Pharmaceuticals (NASDAQ:LBRX) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their dividends, risk, earnings, profitability, valuation, analyst recommendations, institutional ownership and media sentiment.

Alpha Teknova has higher revenue and earnings than LB Pharmaceuticals. LB Pharmaceuticals is trading at a lower price-to-earnings ratio than Alpha Teknova, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Alpha Teknova	$40.52M	7.27	-$17.26M	-$0.32	N/A
LB Pharmaceuticals	N/A	N/A	-$25.20M	-$1.73	N/A

LB Pharmaceuticals has a net margin of 0.00% compared to Alpha Teknova's net margin of -41.07%. LB Pharmaceuticals' return on equity of 0.00% beat Alpha Teknova's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Alpha Teknova	-41.07%	-24.32%	-16.34%
LB Pharmaceuticals	N/A	N/A	N/A

13.8% of Alpha Teknova shares are owned by institutional investors. 13.2% of Alpha Teknova shares are owned by insiders. Comparatively, 5.8% of LB Pharmaceuticals shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

LB Pharmaceuticals has a consensus target price of $45.13, indicating a potential upside of 0.16%. Given LB Pharmaceuticals' stronger consensus rating and higher possible upside, analysts plainly believe LB Pharmaceuticals is more favorable than Alpha Teknova.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Alpha Teknova	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
LB Pharmaceuticals	1 Sell rating(s)	1 Hold rating(s)	6 Buy rating(s)	2 Strong Buy rating(s)	2.90

In the previous week, LB Pharmaceuticals had 6 more articles in the media than Alpha Teknova. MarketBeat recorded 7 mentions for LB Pharmaceuticals and 1 mentions for Alpha Teknova. LB Pharmaceuticals' average media sentiment score of 0.59 beat Alpha Teknova's score of 0.00 indicating that LB Pharmaceuticals is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Alpha Teknova	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
LB Pharmaceuticals	1 Very Positive mention(s)	3 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

LB Pharmaceuticals beats Alpha Teknova on 9 of the 15 factors compared between the two stocks.

How does Alpha Teknova compare to Forte Biosciences?

Alpha Teknova (NASDAQ:TKNO) and Forte Biosciences (NASDAQ:FBRX) are both small-cap healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, risk, analyst recommendations, media sentiment, dividends, institutional ownership, valuation and profitability.

Forte Biosciences has a net margin of 0.00% compared to Alpha Teknova's net margin of -41.07%. Alpha Teknova's return on equity of -24.32% beat Forte Biosciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Alpha Teknova	-41.07%	-24.32%	-16.34%
Forte Biosciences	N/A	-106.17%	-85.50%

Alpha Teknova has higher revenue and earnings than Forte Biosciences. Alpha Teknova is trading at a lower price-to-earnings ratio than Forte Biosciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Alpha Teknova	$40.52M	7.27	-$17.26M	-$0.32	N/A
Forte Biosciences	N/A	N/A	-$69.38M	-$4.64	N/A

13.8% of Alpha Teknova shares are held by institutional investors. Comparatively, 77.6% of Forte Biosciences shares are held by institutional investors. 13.2% of Alpha Teknova shares are held by company insiders. Comparatively, 4.4% of Forte Biosciences shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Forte Biosciences has a consensus price target of $72.50, indicating a potential downside of 5.30%. Given Forte Biosciences' stronger consensus rating and higher probable upside, analysts clearly believe Forte Biosciences is more favorable than Alpha Teknova.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Alpha Teknova	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Forte Biosciences	1 Sell rating(s)	4 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.14

In the previous week, Forte Biosciences had 8 more articles in the media than Alpha Teknova. MarketBeat recorded 9 mentions for Forte Biosciences and 1 mentions for Alpha Teknova. Forte Biosciences' average media sentiment score of 0.35 beat Alpha Teknova's score of 0.00 indicating that Forte Biosciences is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Alpha Teknova	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Forte Biosciences	2 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Alpha Teknova has a beta of 0.64, meaning that its share price is 36% less volatile than the broader market. Comparatively, Forte Biosciences has a beta of 2.6, meaning that its share price is 160% more volatile than the broader market.

Summary

Forte Biosciences beats Alpha Teknova on 9 of the 15 factors compared between the two stocks.

How does Alpha Teknova compare to Cronos Group?

Alpha Teknova (NASDAQ:TKNO) and Cronos Group (NASDAQ:CRON) are both small-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, media sentiment, institutional ownership, risk, valuation, dividends, earnings and analyst recommendations.

Cronos Group has higher revenue and earnings than Alpha Teknova. Alpha Teknova is trading at a lower price-to-earnings ratio than Cronos Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Alpha Teknova	$40.52M	7.27	-$17.26M	-$0.32	N/A
Cronos Group	$146.59M	7.16	-$9.45M	$0.01	281.50

13.8% of Alpha Teknova shares are held by institutional investors. Comparatively, 8.7% of Cronos Group shares are held by institutional investors. 13.2% of Alpha Teknova shares are held by company insiders. Comparatively, 7.8% of Cronos Group shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Alpha Teknova has a beta of 0.64, suggesting that its stock price is 36% less volatile than the broader market. Comparatively, Cronos Group has a beta of 0.9, suggesting that its stock price is 10% less volatile than the broader market.

Cronos Group has a consensus price target of $2.30, suggesting a potential downside of 18.29%. Given Cronos Group's stronger consensus rating and higher possible upside, analysts plainly believe Cronos Group is more favorable than Alpha Teknova.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Alpha Teknova	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Cronos Group	1 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.20

Cronos Group has a net margin of -1.14% compared to Alpha Teknova's net margin of -41.07%. Cronos Group's return on equity of -1.26% beat Alpha Teknova's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Alpha Teknova	-41.07%	-24.32%	-16.34%
Cronos Group	-1.14%	-1.26%	-1.20%

In the previous week, Cronos Group had 2 more articles in the media than Alpha Teknova. MarketBeat recorded 3 mentions for Cronos Group and 1 mentions for Alpha Teknova. Cronos Group's average media sentiment score of 0.25 beat Alpha Teknova's score of 0.00 indicating that Cronos Group is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Alpha Teknova	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Cronos Group	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Cronos Group beats Alpha Teknova on 13 of the 16 factors compared between the two stocks.

How does Alpha Teknova compare to Alvotech?

Alvotech (NASDAQ:ALVO) and Alpha Teknova (NASDAQ:TKNO) are both small-cap healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, earnings, risk, analyst recommendations, institutional ownership, dividends, media sentiment and valuation.

Alvotech has a net margin of -14.36% compared to Alpha Teknova's net margin of -41.07%. Alvotech's return on equity of -11.92% beat Alpha Teknova's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Alvotech	-14.36%	-11.92%	-7.59%
Alpha Teknova	-41.07%	-24.32%	-16.34%

Alvotech presently has a consensus target price of $7.60, indicating a potential upside of 97.97%. Given Alvotech's stronger consensus rating and higher possible upside, equities research analysts clearly believe Alvotech is more favorable than Alpha Teknova.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Alvotech	2 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.00
Alpha Teknova	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

Alvotech has a beta of 0.18, indicating that its stock price is 82% less volatile than the broader market. Comparatively, Alpha Teknova has a beta of 0.64, indicating that its stock price is 36% less volatile than the broader market.

13.8% of Alpha Teknova shares are held by institutional investors. 13.2% of Alpha Teknova shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

In the previous week, Alvotech had 6 more articles in the media than Alpha Teknova. MarketBeat recorded 7 mentions for Alvotech and 1 mentions for Alpha Teknova. Alvotech's average media sentiment score of 1.25 beat Alpha Teknova's score of 0.00 indicating that Alvotech is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Alvotech	6 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Alpha Teknova	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Alvotech has higher revenue and earnings than Alpha Teknova. Alpha Teknova is trading at a lower price-to-earnings ratio than Alvotech, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Alvotech	$588.90M	1.97	$27.92M	-$0.25	N/A
Alpha Teknova	$40.52M	7.27	-$17.26M	-$0.32	N/A

Summary

Alvotech beats Alpha Teknova on 12 of the 16 factors compared between the two stocks.

Get Alpha Teknova News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TKNO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

TKNO vs. The Competition

Export

Metric	Alpha Teknova	Life Sciences Tools & Services Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$294.75M	$9.07B	$6.80B	$13.02B
Dividend Yield	N/A	1.47%	2.60%	10.03%
P/E Ratio	-17.18	59.25	279.73	25.56
Price / Sales	7.27	105.80	649.61	116.36
Price / Cash	N/A	25.63	28.64	34.82
Price / Book	4.30	5.15	11.12	6.36
Net Income	-$17.26M	$57.47B	$3.48B	$347.58M
7 Day Performance	8.02%	1.28%	2.67%	3.24%
1 Month Performance	-5.04%	-2.23%	-2.70%	-2.00%
1 Year Performance	25.53%	15.81%	64.43%	21.31%

Alpha Teknova Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
TKNO Alpha Teknova	0.1308 of 5 stars	$5.50 +3.7%	N/A	+25.0%	$294.75M	$40.52M	N/A	240	Upcoming Earnings
MGTX MeiraGTx	3.6565 of 5 stars	$11.51 -2.6%	$26.00 +125.9%	+55.3%	$1.07B	$81.39M	N/A	300	Gap Up
LBRX LB Pharmaceuticals	1.3093 of 5 stars	$37.14 +6.3%	$40.43 +8.9%	N/A	$1.07B	N/A	N/A	16	Analyst Forecast
FBRX Forte Biosciences	1.2719 of 5 stars	$76.55 -0.1%	$72.50 -5.3%	+697.2%	$1.06B	N/A	N/A	5	High Trading Volume
CRON Cronos Group	0.8499 of 5 stars	$2.84 -0.5%	$2.30 -18.9%	+45.1%	$1.06B	$146.59M	283.78	450	Upcoming Earnings

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:TKNO) was last updated on 8/4/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Alpha Teknova (TKNO) Competitors

TKNO vs. MGTX, LBRX, FBRX, CRON, and ALVO

How does Alpha Teknova compare to MeiraGTx?

Summary

How does Alpha Teknova compare to LB Pharmaceuticals?

Summary

How does Alpha Teknova compare to Forte Biosciences?

Summary

How does Alpha Teknova compare to Cronos Group?

Summary

How does Alpha Teknova compare to Alvotech?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

TKNO vs. The Competition

Alpha Teknova Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Alpha Teknova (TKNO) Competitors

TKNO vs. MGTX, LBRX, FBRX, CRON, and ALVO

How does Alpha Teknova compare to MeiraGTx?

Does the media prefer TKNO or MGTX?

Which has more risk & volatility, TKNO or MGTX?

Is TKNO or MGTX more profitable?

Do analysts rate TKNO or MGTX?

Do insiders & institutionals have more ownership in TKNO or MGTX?

Which has higher earnings and valuation, TKNO or MGTX?

Summary

How does Alpha Teknova compare to LB Pharmaceuticals?

Which has better valuation & earnings, TKNO or LBRX?

Is TKNO or LBRX more profitable?

Do institutionals and insiders believe in TKNO or LBRX?

Do analysts prefer TKNO or LBRX?

Does the media prefer TKNO or LBRX?

Summary

How does Alpha Teknova compare to Forte Biosciences?

Is TKNO or FBRX more profitable?

Which has higher valuation and earnings, TKNO or FBRX?

Do insiders and institutionals hold more shares of TKNO or FBRX?

Do analysts rate TKNO or FBRX?

Does the media refer more to TKNO or FBRX?

Which has more risk and volatility, TKNO or FBRX?

Summary

How does Alpha Teknova compare to Cronos Group?

Which has better valuation & earnings, TKNO or CRON?

Do insiders & institutionals have more ownership in TKNO or CRON?

Which has more risk and volatility, TKNO or CRON?

Do analysts prefer TKNO or CRON?

Is TKNO or CRON more profitable?

Does the media prefer TKNO or CRON?

Summary

How does Alpha Teknova compare to Alvotech?

Is ALVO or TKNO more profitable?

Do analysts rate ALVO or TKNO?

Which has more risk and volatility, ALVO or TKNO?

Do insiders and institutionals believe in ALVO or TKNO?

Does the media favor ALVO or TKNO?

Which has preferable valuation and earnings, ALVO or TKNO?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

TKNO vs. The Competition

Alpha Teknova Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools